An intermediate descriptive analysis 3 months after discharge from this multicenter, ambispective and observational study conducted in 16 hospitals in Madrid (Spain) with survivors of the first COVID-19 outbreak in the ICU. Sponsored by SENDIMAD, funded by Nutricia-Danone Specialized Nutrition.